PELI1 and cancer: we found that combination of PELI1 knockdown and EGFR inhibition significantly decreased metastatic potential of cancer cells to lung in caudal vein xenograft models compared to the either single treatment, as demonstrated by reduced number of micrometastatic nodules (Fig. 5H).